Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Werner

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Gynecologic Oncology|May 22, 2012
Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomasIngfrid S Haldorsen, Anna Berg, Henrica M J Werner, et al.
Cancers|April 3, 2021
Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial CancerKristina Lindemann, Elisabeth Smogeli, Milada Cvancarova Småstuen, et al.
BJC Reports|November 8, 2024
Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancerMarta E Hjelmeland, Hilde E Lien, Hege F Berg, et al.
Cancers|November 27, 2021
Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular ClassificationJenneke C Kasius, Johanna M A Pijnenborg, Kristina Lindemann, et al.
European Journal of Cancer (Oxford, England : 1990)|April 5, 2026
Country-of-birth disparities in high-grade endometrial cancer: A European-first population-based analysis on incidence, age at presentation, and survival in an equal-access health system in the NetherlandsJanneke J E Kieviet, Johanna M A Pijnenborg, Maaike van der Aa, et al.
Plos One|March 4, 2014
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancerHenrica M J Werner, Jone Trovik, Mari K Halle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2015
Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial CancerJi-Yeon Yang, Henrica M J Werner, Jie Li, et al.
European Radiology|March 29, 2012
Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologistsIngfrid S Haldorsen, Jenny A Husby, Henrica M J Werner, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 1, 2021
Impact of <i>MDM2</i> promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancerReham Helwa, Liv B Gansmo, Merete Bjørnslett, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2014
Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesionsIngvild Løberg Tangen, Henrica M J Werner, Anna Berg, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|May 22, 2012
Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomasIngfrid S Haldorsen, Anna Berg, Henrica M J Werner, et al.
Cancers|April 3, 2021
Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial CancerKristina Lindemann, Elisabeth Smogeli, Milada Cvancarova Småstuen, et al.
BJC Reports|November 8, 2024
Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancerMarta E Hjelmeland, Hilde E Lien, Hege F Berg, et al.
Cancers|November 27, 2021
Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular ClassificationJenneke C Kasius, Johanna M A Pijnenborg, Kristina Lindemann, et al.
European Journal of Cancer (Oxford, England : 1990)|April 5, 2026
Country-of-birth disparities in high-grade endometrial cancer: A European-first population-based analysis on incidence, age at presentation, and survival in an equal-access health system in the NetherlandsJanneke J E Kieviet, Johanna M A Pijnenborg, Maaike van der Aa, et al.
Plos One|March 4, 2014
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancerHenrica M J Werner, Jone Trovik, Mari K Halle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2015
Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial CancerJi-Yeon Yang, Henrica M J Werner, Jie Li, et al.
European Radiology|March 29, 2012
Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologistsIngfrid S Haldorsen, Jenny A Husby, Henrica M J Werner, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 1, 2021
Impact of <i>MDM2</i> promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancerReham Helwa, Liv B Gansmo, Merete Bjørnslett, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2014
Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesionsIngvild Løberg Tangen, Henrica M J Werner, Anna Berg, et al.
Pageof 10